Trial intelligence / Profile preview

Lithium in Progressive MS

NCT01259388Phase 2Completed

Sponsor
VA Office of Research & Development
Start
May 2011
Primary completion
Aug 2015
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 2 trial of lithium carbonate in multiple sclerosis (MS), sponsored by VA Office of Research & Development. Started May 2011; status: completed.

02

Drugs

lithium carbonate
03

Conditions

multiple sclerosis (MS)

Beyond the preview

Go deeper on NCT01259388.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01259388.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call